Azenta Inc
NASDAQ:AZTA

Watchlist Manager
Azenta Inc Logo
Azenta Inc
NASDAQ:AZTA
Watchlist
Price: 45.16 USD -0.81% Market Closed
Market Cap: 2.2B USD
Have any thoughts about
Azenta Inc?
Write Note

Azenta Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Azenta Inc
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Azenta Inc
NASDAQ:AZTA
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Current Portion of Long-Term Debt
$4.1B
CAGR 3-Years
501%
CAGR 5-Years
44%
CAGR 10-Years
3%
Danaher Corp
NYSE:DHR
Current Portion of Long-Term Debt
$1.2B
CAGR 3-Years
456%
CAGR 5-Years
2%
CAGR 10-Years
33%
Mettler-Toledo International Inc
NYSE:MTD
Current Portion of Long-Term Debt
$185.8m
CAGR 3-Years
51%
CAGR 5-Years
31%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Current Portion of Long-Term Debt
$1.2B
CAGR 3-Years
137%
CAGR 5-Years
66%
CAGR 10-Years
50%
No Stocks Found

Azenta Inc
Glance View

Market Cap
2.1B USD
Industry
Life Sciences Tools & Services

Azenta, Inc. provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. The company is headquartered in Chelmsford, Massachusetts and currently employs 2,900 full-time employees. Azenta provides a full suite of cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's services include genomics services, sample and management solutions, sample and material storage, clinical trial management, drug products and cell therapies, sample prep and lab services, lab moving and biological transport, information technology solutions, and business continuity and risk mitigation. Azenta has operations in North America, Europe and Asia.

AZTA Intrinsic Value
27.02 USD
Overvaluation 40%
Intrinsic Value
Price

See Also

Back to Top